Epidemiology and etiologies-atrial fibrillation

(Circ A&E 2018;11:e006350)

  • 1–2% of pop. has AF (10% of those age ≥80); M >F; lifetime risk ~25%; mean age 75 y

Acute (up to 50% w/o identifiable cause)

  • Cardiac:
    • HF, new CMP, myo/pericarditis, ischemia/MI, HTN crisis,
    • valve dis., cardiac surg
  • Pulmonary:
    • acute pulmonary disease or hypoxemia (eg, COPD flare, PNA),
    • PE, OSA
  • Metabolic:
    • high catecholamine states (stress, infection, postop, pheo),
    • thyrotoxicosis
  • Neurogenic:
    • subarachnoid hemorrhage,
    • ischemic stroke
  • Drugs:
    • alcohol, cocaine, amphetamines, smoking, ibrutinib

Chronic:

  • ↑ age, HTN, ischemia, valve dis. (MV, TV, AoV), CMP, hyperthyroidism, obesity
  • Aggressive mgmt of HTN, OSA & EtOH (NEJM 2020;382:20) to ↓ risk

Explain by ChatGPT

  • AF can be asymptomatic or associated with fatigue, dyspnea, palpitations, or chest pain

Epidemiology and etiologies-atrial fibrillation

  • 1–2% of the population has AF (10% of those age ≥80);

  • Acute (up to 50% w/o identifiable cause)

  • Cardiac: HF, new CMP, myo/pericarditis, ischemia/MI, HTN crisis, valve dis., cardiac surg

  • Pulmonary: acute pulmonary disease or hypoxemia (eg, COPD flare, PNA), PE, OSA

  • Metabolic: high catecholamine states (stress, infection, postop, pheo), thyrotoxicosis

  • Drugs: alcohol, cocaine, amphetamines, smoking, ibrutinib

  • Neurogenic: subarachnoid hemorrhage, ischemic stroke

  • Chronic: ↑ age, HTN, ischemia, valve dis. (MV, TV, AoV), CMP, hyperthyroidism, obesity

  • Aggressive mgmt of HTN, OSA & EtOH (NEJM 2020;382:20) to ↓ risk

  • AF can be asymptomatic or associated with fatigue, dyspnea, palpitations, or chest pain

窩的英文不太好

  • AF 可能沒有症狀或伴有疲勞、呼吸困難、心悸或胸痛

流行病學和病因學——房顫

  • 1-2% 的人口患有房顫(其中 10% 的年齡≥80 歲);

  • 急性(高達 50% w/o 可識別原因)

  • 心臟:心力衰竭、新 CMP、肌病/心包炎、缺血/心肌梗死、高血壓危象、瓣膜病、心臟外科手術

  • 肺部:急性肺部疾病或低氧血症(例如,COPD 發作、PNA)、PE、OSA

  • 代謝:高兒茶酚胺狀態(壓力、感染、術後、pheo)、甲狀腺毒症

  • 藥物:酒精、可卡因、苯丙胺、吸煙、依魯替尼

  • 神經源性:蛛網膜下腔出血、缺血性中風

  • 慢性:↑ 年齡、高血壓、局部缺血、瓣膜病。 (MV, TV, AoV), CMP, 甲亢, 肥胖

  • HTN、OSA 和 EtOH 的積極管理 (NEJM 2020;382:20) 到 ↓ 風險

  • AF 可能沒有症狀或伴有疲勞、呼吸困難、心悸或胸痛